Paul W. Noble, MD
Chair, Department of Medicine
Director, Women's Guild Lung Institute
Paul W. Noble, MD, is Chair of the Department of Medicine and Director of the Women's Guild Lung Institute at Cedars-Sinai.
Dr. Noble's clinical areas of expertise are interstitial lung disease, conducting clinical trials in idiopathic pulmonary fibrosis, connective tissue disease-related pulmonary disease and brochiolitis. His research focuses on cellular and molecular mechanisms of lung inflammation and fibrosis, the role of lung stem cells in pulmonary fibrosis and the role of host defense in lung inflammation and fibrosis and is heavily supported by the National Heart, Lung and Blood Institute at the National Institutes of Health.
Dr. Noble is a prolific author. His original research has been published in numerous peer-review journals, including the New England Journal of Medicine, Science and Nature Medicine. As deputy editor of the Journal of Clinical Investigation, Dr. Noble has been a leading contributor to discovery in lung disease. An elected member of the American Society of Clinical Investigation and the American Association of Physicians, he is currently deputy editor of the Journal of Clinical Investigation and has been a member of the editorial boards for the American Journal of Respiratory Cell and Molecular Biology and the American Journal of Respiratory and Critical Care Medicine. He also has been a member of the scientific advisory board of the American Asthma Foundation.
After earning his bachelor’s degree at Haverford College and his medical degree from New York University School of Medicine, Dr. Noble completed his residency and chief residency in internal medicine at the University of California, San Francisco. He completed pulmonary and critical care fellowships at the University of Colorado Health Sciences Center and the National Jewish Center for Immunology and Respiratory Medicine.
Prior to joining Cedars-Sinai, Dr. Noble was a Charles Johnson MD Distinguished Professor and Chief of the Division of Pulmonary, Allergy and Critical Care Medicine at Duke University Medical Center in Durham, North Carolina.
As an assistant professor of medicine at The Johns Hopkins University School of Medicine, he was founder and director of the Interstitial Lung Disease Clinic, before moving on to become professor of medicine and associate chief of pulmonary and critical care at Yale University School of Medicine. At Yale, he also formed an interstitial lung disease clinic and, at Duke, he propelled his division to the highest ranks in the nation for clinical care, research productivity and National Institutes of Health funding.